Civic Intelligence

Melanoma Research Foundation

990 • Fiscal year 2018 • EIN 80-0671049

Apr 01, 2017 to Mar 31, 2018 • Filed on Dec 21, 2018

1411 K Street NW No 800Washington, DC 20005

(202) 347-9675

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

89th percentile

0.69x

Higher debt load relative to assets than 89% of similar nonprofits.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2018

Liabilities / Revenue

88th percentile

0.75x

Higher debt load relative to revenue than 88% of similar nonprofits.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2018

Net Margin

20th percentile

-10%

Higher net margin than 20% of similar nonprofits.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2018

Top Officer Pay

50th percentile

$0

Higher top officer pay than 50% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2018

Asset Growth

93rd percentile

92%

Faster asset growth than 93% of similar nonprofits.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2017 to 2018

Revenue Growth

95th percentile

143%

Faster revenue growth than 95% of similar nonprofits.

2018 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2017 to 2018

Assets

Up

$585,783

Up $280,569 (+92%) from 2017

Net Assets

Down

$179,537

Down $56,345 (-24%) from 2017

Liabilities

Up

$406,246

Up $336,914 (+486%) from 2017

Revenue

Up

$544,135

Up $320,129 (+143%) from 2017

Expenses

Up

$600,480

Up $357,586 (+147%) from 2017

Net Income

Down

-$56,345

Down $37,457 (-198%) from 2017

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2014: $1,186,063Liabilities 2014: $1,128,281Net Assets 2014: $57,7822014Assets 2015: $1,251,181Liabilities 2015: $1,199,631Net Assets 2015: $51,5502015Assets 2016: $987,202Liabilities 2016: $732,432Net Assets 2016: $254,7702016Assets 2017: $305,214Liabilities 2017: $69,332Net Assets 2017: $235,8822017Assets 2018: $585,783Liabilities 2018: $406,246Net Assets 2018: $179,5372018Assets 2019: $603,844Liabilities 2019: $140,085Net Assets 2019: $463,7592019Assets 2020: $558,333Liabilities 2020: $83,583Net Assets 2020: $474,7502020Assets 2021: $0Liabilities 2021: $0Net Assets 2021: $02021

Highlighted filing

2018

Assets$585,783
Liabilities$406,246
Net Assets$179,537

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2014: $854,480Expenses 2014: $957,136Net Income 2014: -$102,6562014Revenue 2015: $135,460Expenses 2015: $164,231Net Income 2015: -$28,7712015Revenue 2016: $708,867Expenses 2016: $543,146Net Income 2016: $165,7212016Revenue 2017: $224,006Expenses 2017: $242,894Net Income 2017: -$18,8882017Revenue 2018: $544,135Expenses 2018: $600,480Net Income 2018: -$56,3452018Revenue 2019: $375,277Expenses 2019: $91,055Net Income 2019: $284,2222019Revenue 2020: $390,534Expenses 2020: $379,543Net Income 2020: $10,9912020Revenue 2021: $320,000Expenses 2021: $314,821Net Income 2021: $5,1792021

Highlighted filing

2018

Revenue$544,135
Expenses$600,480
Net Income-$56,345
Jump To
Filing Snapshot
Filing Period
Apr 1, 2017 to Mar 31, 2018
Signed
Dec 21, 2018
Return Version
2017v2.3
Gross Receipts
$544,135
Mission and Program Overview

Mission

The mission of the melanoma research foundation breakthrough consortium, inc. (the consortium) is to accelerate the research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients. The consortium will develop collaborative, multi-sector partnerships across the breadth of melanoma disciplines - basic, translational and clinical science - to expedite development of combinations of therapies as well as novel single agents; support pre-clinical research to facilitate rational combinations; create a virtual annotated specimen biorepository; and identify biomarkers that have prognostic and predictive value or value as a new therapeutic target.

Supports clinical trials, drug develop. & research relating to treatment & prevention of melanoma.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$47,655$336,930▲ $289,275
Prepaid Expenses and Deferred Charges$5,322$4,998▼ $324
Total Assets$305,214$585,783▲ $280,569
Other Assets Total$252,237$243,855▼ $8,382
Liabilities
Grants Payable$0$351,593▲ $351,593
Accounts Payable and Accrued Expenses$69,332$54,653▼ $14,679
Total Liabilities$69,332$406,246▲ $336,914
Net Assets / Fund Balance
Temporarily Rstr Net Assets$0$92,437▲ $92,437
Unrestricted Net Assets$235,882$87,100▼ $148,782
Total Net Assets Fund Balance$235,882$179,537▼ $56,345
Total Liabilities and Net Assets / Fund Balance$305,214$585,783▲ $280,569

Asset Categories

AssetBook ValueDepreciationBasis
Other Assets Org$243,855--
Compensation and Service Providers

Board Members and Trustees

NameTitle
Steve SilversteinChairman & President
Lynn Schuchter MdExecutive Vice President
Jeffrey E Gershenwald MdBoard Member
Keith T Flaherty MdBoard Member
Michael B Atkins MdBoard Member
ZE'EV RONAI PHDBoard Member
Meenhard Herlyn Dvm DscSecretary
Anthony T HendricksonTreasurer & CFO
Revenue and Support

Revenue Composition

Contributions and Grants
$544,135
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$341,421
Change in Net Assets
$-56,345
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$523,938
Other Expenses$76,542
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$523,938--$523,938
Fees for Services Other$32,032--$32,032
Insurance$21,598--$21,598
Travel$11,066--$11,066
Conferences and Meetings$8,748--$8,748
Fees for Services Accounting$2,548--$2,548
Other Expenses$441--$441
Office Expenses$109--$109
Total Functional Expenses$600,480$0$0$600,480
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Georgetown UniversityWashington, DC501(c)(3)General Support$273,938
Vanderbilt UniversityWashington, DC501(c)(3)Young Investigator Award$250,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
Yes
Management duties delegated
Yes

Governance Explanations

Form 990, Part VI, Section A, Line 3

The consortium hires martin & associates to perform the daily operations and managerial duties such as developing agendas, providing insights and guidance to the board of directors, and developing strategic partnerships with other organizations. In addition, they also establish in conjunction with consortium members, appropriate protocols and procedures needed for the work of the group; with consortium representatives, meets with appropriate pharmaceutical companies for the purposes of securing support for clinical trials; and coordinates with the members of the consortium to determine the appropriate placement of trials.

Form 990, Part VI, Section A, Line 6

The consortium has one class of members. The qualifications and eligibility for membership and the manner of admission into membership shall be prescribed by resolution of the board of directors and/or by any similarly prescribed rules and regulations which the board of directors may promulgate.

Form 990, Part VI, Section A, Line 7A

Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.

Form 990, Part VI, Section A, Line 7B

Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.

Form 990, Part VI, Section B, Line 11B

The consortium hires an independent accounting firm to prepare the federal form 990. Upon submission of the final draft 990, the board of directors reviews and approves prior to filing with the internal revenue service.

Form 990, Part VI, Section B, Line 12C

Full disclosure, by notice in writing, shall be made by the interested parties to the full board of directors with respect to all conflicts of interest. Following full disclosure of a potential conflict, the board of directors will determine if a conflict exists. Should a conflict exist, that interested person will not participate in any discussion or vote on the matter.

Form 990, Part VI, Section C, Line 19

The governing documents, conflicts of interest policy, and financial statements are available to the public upon request.

Filing and Contact Details

Filer

Filer Name
Melanoma Research Foundation
EIN
80-0671049
Phone
2023479675
Address
1411 K STREET NW NO 800, WASHINGTON, DC 20005

Signing Officer

Name
Anthony T Hendrickson
Title
Treasurer & CFO
Phone
2023479675
Signed
2018-12-21
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Anthony T Hendrickson
Formed
2010
Legal Domicile
Dc
Voting Board Members
8
Independent Board Members
8
Employees
0
Volunteers
8

Preparer

Firm
Marcum Llp
Address
1899 L STREET NW, WASHINGTON, DC 20036
Preparer
Frank H Smith
Phone
2028225000
Supplemental Narrative

Financial Statement Notes

PART X, LINE 2:

The consortium performed an evaluation of uncertain income taxes for the year ended march 31, 2018, and determined that there were no matters that would require recognition in the financial statements or that may have any effect on its tax-exempt status.

Raw XML AppendixShowing 400 of 421 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt069332
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt054653
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SUPPORTS CLINICAL TRIALS, DRUG DEVELOP. & RESEARCH RELATING TO TREATMENT & PREVENTION OF MELANOMA.
IRS990/AllOtherContributionsAmt0341421
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ANTHONY T HENDRICKSON
IRS990/BooksInCareOfDetail/PhoneNum02023479675
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01411 K STREET NW NO 800
IRS990/BooksInCareOfDetail/USAddress/CityNm0WASHINGTON
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0DC
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020005
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt047655
IRS990/CashNonInterestBearingGrp/EOYAmt0336930
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt08748
IRS990/ConferencesMeetingsGrp/TotalAmt08748
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0544135
IRS990/CYGrantsAndSimilarPaidAmt0523938
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt076542
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-56345
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0600480
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0544135
IRS990/DecisionsSubjectToApprovaInd01
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd01
IRS990/Desc0THE CONSORTIUM SEEKS TO ACCELERATE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. SUCCESS IN THIS ENDEAVOR ALSO FURTHERS THE EXEMPT PURPOSE OF THE MELANOMA RESEARCH FOUNDATION (MRF). IN ORDER TO ACHIEVE ITS MISSION, THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES- BASIC, TRANSLATIONAL AND CLINICAL SCIENCE- TO EXPEDITE DEVELOPMENT OF COMBINATION THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRECLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS NEW THERAPEUTIC TARGETS WHICH REQUIRED THE EXPERTISE OF A MD AND PROJECT MANAGER. IN ADDITION, THE CONSORTIUM'S BOARD OF DIRECTORS AND PARTICIPATING RESEARCH INSTITUTIONS WILL CONDUCT OUTREACH TO MULTI SECTOR PARTNERS WITH AN INTEREST OR INVESTMENT IN MELANOMA RESEARCH TO ENSURE THAT THE CONSORTIUM IS AWARE OF ANY IMPORTANT DEVELOPMENTS OR PROMISING RESEARCH IN THE FIELD OF MELANOMA.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0600480
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt02548
IRS990/FeesForServicesAccountingGrp/TotalAmt02548
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt032032
IRS990/FeesForServicesOtherGrp/TotalAmt032032
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0STEVE SILVERSTEIN
IRS990/Form990PartVIISectionAGrp/PersonNm1LYNN SCHUCHTER MD
IRS990/Form990PartVIISectionAGrp/PersonNm2MEENHARD HERLYN DVM DSC
IRS990/Form990PartVIISectionAGrp/PersonNm3ANTHONY T HENDRICKSON
IRS990/Form990PartVIISectionAGrp/PersonNm4MICHAEL B ATKINS MD
IRS990/Form990PartVIISectionAGrp/PersonNm5KEITH T FLAHERTY MD
IRS990/Form990PartVIISectionAGrp/PersonNm6JEFFREY E GERSHENWALD MD
IRS990/Form990PartVIISectionAGrp/PersonNm7ZE'EV RONAI PHD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIRMAN & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1EXECUTIVE VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3TREASURER & CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt6BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt7BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02010
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GrantAmt0523938
IRS990/GrantsPayableGrp/BOYAmt00
IRS990/GrantsPayableGrp/EOYAmt0351593
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0523938
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0523938
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0544135
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt08
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt021598
IRS990/InsuranceGrp/TotalAmt021598
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0DC
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM, INC. (THE CONSORTIUM) IS TO ACCELERATE THE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES - BASIC, TRANSLATIONAL AND CLINICAL SCIENCE - TO EXPEDITE DEVELOPMENT OF COMBINATIONS OF THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRE-CLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS A NEW THERAPEUTIC TARGET.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0235882
IRS990/NetAssetsOrFundBalancesEOYAmt0179537
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ProgramServicesAmt0109
IRS990/OfficeExpensesGrp/TotalAmt0109
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0252237
IRS990/OtherAssetsTotalGrp/EOYAmt0243855
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0MISCELLANEOUS
IRS990/OtherExpensesGrp/ProgramServicesAmt0441
IRS990/OtherExpensesGrp/TotalAmt0441
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt05322
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt04998
IRS990/PrincipalOfficerNm0ANTHONY T HENDRICKSON
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0224006
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt0240096
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-18888
IRS990/PYSalariesCompEmpBnftPaidAmt02798
IRS990/PYTotalExpensesAmt0242894
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0224006
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-56345
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt0202714
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0760514428
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt00
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt0243855
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0DUE FROM AFFILIATE
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM PERFORMED AN EVALUATION OF UNCERTAIN INCOME TAXES FOR THE YEAR ENDED MARCH 31, 2018, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalBookValueOtherAssetsAmt0243855
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0273938
IRS990ScheduleI/RecipientTable/CashGrantAmt1250000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(C)(3)
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0GENERAL SUPPORT
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1YOUNG INVESTIGATOR AWARD
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0GEORGETOWN UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1VANDERBILT UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientEIN0530196603
IRS990ScheduleI/RecipientTable/RecipientEIN1600476822
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt037TH AND O STREET NW
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1750 1ST STREET NE SUITE 1110
IRS990ScheduleI/RecipientTable/USAddress/CityNm0WASHINGTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm1WASHINGTON
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0DC
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1DC
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd020057
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd120002
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM MONITORS THE USE OF GRANT FUNDS BY THE GRANTEES THROUGH ITS ANNUAL FINANCIAL AND SCIENTIFIC PROGRESS REPORTS. IF THE AWARD IS A MULTI-YEAR AWARD, THE GRANTEE IS REQUIRED TO SUBMIT INTERIM FINANCIAL AND SCIENTIFIC PROGRESS REPORTS UPON COMPLETION OF EACH YEAR (WITH FINAL REPORTS DUE WITHIN 60 DAYS OF THE COMPLETION OF THE GRANT CYCLE). FUNDING IS WITHHELD FOR THE SUBSEQUENT YEAR UNTIL THE INTERIM REPORTS ARE RECEIVED. IF THE AWARD IS A SINGLE-YEAR AWARD, ONLY A FINAL FINANCIAL AND SCIENTIFIC PROGRESS REPORT IS DUE WITHIN 60 DAYS OF COMPLETION OF THE GRANT.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt02
IRS990ScheduleI/TotalOtherOrgCnt00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM HIRES MARTIN & ASSOCIATES TO PERFORM THE DAILY OPERATIONS AND MANAGERIAL DUTIES SUCH AS DEVELOPING AGENDAS, PROVIDING INSIGHTS AND GUIDANCE TO THE BOARD OF DIRECTORS, AND DEVELOPING STRATEGIC PARTNERSHIPS WITH OTHER ORGANIZATIONS. IN ADDITION, THEY ALSO ESTABLISH IN CONJUNCTION WITH CONSORTIUM MEMBERS, APPROPRIATE PROTOCOLS AND PROCEDURES NEEDED FOR THE WORK OF THE GROUP; WITH CONSORTIUM REPRESENTATIVES, MEETS WITH APPROPRIATE PHARMACEUTICAL COMPANIES FOR THE PURPOSES OF SECURING SUPPORT FOR CLINICAL TRIALS; AND COORDINATES WITH THE MEMBERS OF THE CONSORTIUM TO DETERMINE THE APPROPRIATE PLACEMENT OF TRIALS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE CONSORTIUM HAS ONE CLASS OF MEMBERS. THE QUALIFICATIONS AND ELIGIBILITY FOR MEMBERSHIP AND THE MANNER OF ADMISSION INTO MEMBERSHIP SHALL BE PRESCRIBED BY RESOLUTION OF THE BOARD OF DIRECTORS AND/OR BY ANY SIMILARLY PRESCRIBED RULES AND REGULATIONS WHICH THE BOARD OF DIRECTORS MAY PROMULGATE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4THE CONSORTIUM HIRES AN INDEPENDENT ACCOUNTING FIRM TO PREPARE THE FEDERAL FORM 990. UPON SUBMISSION OF THE FINAL DRAFT 990, THE BOARD OF DIRECTORS REVIEWS AND APPROVES PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5FULL DISCLOSURE, BY NOTICE IN WRITING, SHALL BE MADE BY THE INTERESTED PARTIES TO THE FULL BOARD OF DIRECTORS WITH RESPECT TO ALL CONFLICTS OF INTEREST. FOLLOWING FULL DISCLOSURE OF A POTENTIAL CONFLICT, THE BOARD OF DIRECTORS WILL DETERMINE IF A CONFLICT EXISTS. SHOULD A CONFLICT EXIST, THAT INTERESTED PERSON WILL NOT PARTICIPATE IN ANY DISCUSSION OR VOTE ON THE MATTER.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6THE GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION A, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION A, LINE 7B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleR/AssetExchangeInd00
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd00
IRS990ScheduleR/AssetSaleToOtherOrgInd00
IRS990ScheduleR/DivRelatedOrganizationInd00
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd01
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd00
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd00
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingNACd0N/A
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN0760514428
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt0501(C)(3)
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd0TX
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt0RESEARCH, AWARENESS AND ADVOCACY FOR MELANOMA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PublicCharityStatusTxt0LINE 7
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt01411 K STREET NW SUITE 800
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/CityNm0WASHINGTON
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/StateAbbreviationCd0DC
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/ZIPCd020005
IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd00
IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd00
IRS990ScheduleR/PaidEmployeesSharingInd00
IRS990ScheduleR/PerformOfServicesByOtherOrgInd00
IRS990ScheduleR/PerformOfServicesForOthOrgInd00
IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd00
IRS990ScheduleR/ReimbursementPaidByOtherOrgInd00
IRS990ScheduleR/ReimbursementPaidToOtherOrgInd00
IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd00
IRS990ScheduleR/RentalOfFcltsFromOthOrgInd00
IRS990ScheduleR/SharingOfFacilitiesInd01
IRS990ScheduleR/TransferFromOtherOrgInd00
IRS990ScheduleR/TransferToOtherOrgInd00
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TemporarilyRstrNetAssetsGrp/BOYAmt00
IRS990/TemporarilyRstrNetAssetsGrp/EOYAmt092437
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0305214
IRS990/TotalAssetsEOYAmt0585783
IRS990/TotalAssetsGrp/BOYAmt0305214
IRS990/TotalAssetsGrp/EOYAmt0585783
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0544135
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt00
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0600480
IRS990/TotalFunctionalExpensesGrp/TotalAmt0600480
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt069332
IRS990/TotalLiabilitiesEOYAmt0406246
IRS990/TotalLiabilitiesGrp/BOYAmt069332
IRS990/TotalLiabilitiesGrp/EOYAmt0406246
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0235882
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0179537
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0600480
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0544135
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt08
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0305214
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0585783
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TravelGrp/ProgramServicesAmt011066
IRS990/TravelGrp/TotalAmt011066
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UnrestrictedNetAssetsGrp/BOYAmt0235882
IRS990/UnrestrictedNetAssetsGrp/EOYAmt087100
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt01411 K STREET NW NO 800
IRS990/USAddress/CityNm0WASHINGTON
IRS990/USAddress/StateAbbreviationCd0DC
IRS990/USAddress/ZIPCd020005
IRS990/VotingMembersGoverningBodyCnt08
IRS990/VotingMembersIndependentCnt08
IRS990/WebsiteAddressTxt0WWW.MELANOMA.ORG/RESEARCH/MRF-BREAKTHROUGH-CONSOR
IRS990/WhistleblowerPolicyInd01
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ANTHONY T HENDRICKSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER & CFO
ReturnHeader/BusinessOfficerGrp/PhoneNum02023479675
ReturnHeader/BusinessOfficerGrp/SignatureDt02018-12-21
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0BREAKTHROUGH CONSORTIUM INC
ReturnHeader/Filer/BusinessNameControlTxt0MELA
ReturnHeader/Filer/EIN0800671049
ReturnHeader/Filer/PhoneNum02023479675
ReturnHeader/Filer/USAddress/AddressLine1Txt01411 K STREET NW NO 800
ReturnHeader/Filer/USAddress/CityNm0WASHINGTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0DC

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings